TNF alpha is an effective therapeutic target for rheumatoid arthritis

被引：64

作者：

Feldmann, M

Brennan, FM

Elliott, MJ

Williams, RO

Maini, RN

机构：

[1] Kennedy Institute of Rheumatology, Sunley Division, London, W6 8LW, Avenue Hammersmith

来源：

RECEPTOR ACTIVATION BY ANTIGENS, CYTOKINES, HORMONES, AND GROWTH FACTORS | 1995年 / 766卷

关键词：

D O I：

10.1111/j.1749-6632.1995.tb26675.x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：272 / 278

页数：7

共 19 条

[1] BRENNAN FM, 1989, LANCET, V2, P244
[2] CYTOKINE PRODUCTION IN CULTURE BY CELLS ISOLATED FROM THE SYNOVIAL-MEMBRANE
BRENNAN, FM
CHANTRY, D
JACKSON, AM
MAINI, RN
FELDMANN, M
[J]. JOURNAL OF AUTOIMMUNITY, 1989, 2 : 177 - 186
[3] BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449
[4] BUCHAN G, 1988, CLIN EXP IMMUNOL, V71, P295
[5] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS
ELLIOTT, MJ
MAINI, RN
FELDMANN, M
KALDEN, JR
ANTONI, C
SMOLEN, JS
LEEB, B
BREEDVELD, FC
MACFARLANE, JD
BIJL, H
WOODY, JN
[J]. LANCET, 1994, 344 (8930) : 1105 - 1110
[6] ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362
[7] REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS
ELLIOTT, MJ
MAINI, RN
FELDMANN, M
LONGFOX, A
CHARLES, P
BIJL, H
WOODY, JN
[J]. LANCET, 1994, 344 (8930) : 1125 - 1127
[8] HOW IMPORTANT ARE T-CELLS IN CHRONIC RHEUMATOID SYNOVITIS
FIRESTEIN, GS
ZVAIFLER, NJ
[J]. ARTHRITIS AND RHEUMATISM, 1990, 33 (06): : 768 - 773
[9] AN INTERLEUKIN-1 LIKE FACTOR STIMULATES BONE-RESORPTION INVITRO
GOWEN, M
WOOD, DD
IHRIE, EJ
MCGUIRE, MKB
RUSSELL, RGG
[J]. NATURE, 1983, 306 (5941) : 378 - 380
[10] THE SHARED EPITOPE HYPOTHESIS - AN APPROACH TO UNDERSTANDING THE MOLECULAR-GENETICS OF SUSCEPTIBILITY TO RHEUMATOID-ARTHRITIS
GREGERSEN, PK
SILVER, J
WINCHESTER, RJ
[J]. ARTHRITIS AND RHEUMATISM, 1987, 30 (11): : 1205 - 1213